Girentuximab
Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Carbonic Anhydrase
CAS Number
916138-87-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ANT-37192-100ug 100 µg
BRSV G/Major surface glycoprotein G Antibody, InVivo Block/Neutralizing Antibody
Ask
View Details